However, the core consensus encompasses the following: magnetic resonance imaging (MRI) is established as the preferred imaging modality; the combination of anti-tumor necrosis factor (anti-TNF) agents and surgical intervention constitutes the standard protocol for Crohn's disease-associated anal fistulas; and sphincter-preserving techniques are prioritized in clinical practice. The gene discussed is TNF; the disease is Anal fistula.